Effects of apolipoprotein E polymorphism on plasma lipoprotein(a) levels
- PMID: 8010888
Effects of apolipoprotein E polymorphism on plasma lipoprotein(a) levels
Abstract
Effects of apolipoprotein E (apo E) genetic polymorphism on plasma lipoprotein(a) (Lp(a)) levels were investigated in 305 civil service workers (158 men and 147 women). Plasma Lp(a) levels were measured by ELISA. Apo E phenotypes were determined from plasma by isoelectric focusing, Western blotting and immunostaining, as we previously reported. A total of 305 subjects were divided into the three apo E groups; apo E2 group (n = 19 for apo E3/2 and n = 4 for apo E4/2), Apo E3/3 group (n = 224) and apo E4/3 group (n = 58). Mean levels of plasma Lp(a) were 14.2 mg/dl. Plasma Lp(a) levels were significantly lower in the apo E2 group (6.6 mg/dl) than in the apo E3/3 (15.1 mg/dl) and E4/3 (13.7 mg/dl) groups. Plasma total cholesterol (T-chol) and low density lipoprotein (LDL)-chol levels were significantly lower in the apo E2 group than in the apo E4/3 group and tended to be highest in the apo E4/3 group. A significant positive correlation was noted between plasma Lp(a) levels and plasma LDL-chol levels, indicating that the effects of apo E polymorphism on plasma Lp(a) levels were parallel to its effects on plasma LDL-chol levels. In women plasma Lp(a) levels were significantly lower in the apo E2 group than in the apo E3/3 and E4/3 groups, whereas in men plasma Lp(a) levels tended to be lower in the apo E2 group but no significant difference was noted among the three apo E groups. It is concluded that plasma Lp(a) levels are, at least in part, modulated by apo E polymorphism (particularly apo E2) and that there is a gender difference in the effects of apo E polymorphism on plasma Lp(a) levels.
Similar articles
-
Apolipoprotein E phenotype affects the malondialdehyde-modified LDL concentration and forearm endothelial function in postmenopausal women.Clin Endocrinol (Oxf). 2004 Nov;61(5):619-25. doi: 10.1111/j.1365-2265.2004.02145.x. Clin Endocrinol (Oxf). 2004. PMID: 15521966
-
Apolipoprotein E polymorphism modulates the association between obesity and dyslipidemias during young adulthood: The Bogalusa Heart Study.Metabolism. 2001 Jun;50(6):696-702. doi: 10.1053/meta.2001.23299. Metabolism. 2001. PMID: 11398147
-
Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women.Coll Antropol. 1998 Jun;22(1):149-55. Coll Antropol. 1998. PMID: 10097431
-
[Apolipoprotein E and its alleles in healthy subjects and in atherosclerosis].Ann Biol Clin (Paris). 1998 Nov-Dec;56(6):651-9. Ann Biol Clin (Paris). 1998. PMID: 9853024 Review. French.
-
[Apolipoprotein E].Nihon Rinsho. 1994 Dec;52(12):3124-32. Nihon Rinsho. 1994. PMID: 7853700 Review. Japanese.
Cited by
-
Lipoprotein(a) Mass Levels Increase Significantly According to APOE Genotype: An Analysis of 431 239 Patients.Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):580-588. doi: 10.1161/ATVBAHA.116.308704. Epub 2017 Jan 5. Arterioscler Thromb Vasc Biol. 2017. PMID: 28062489 Free PMC article.
-
Genome- and exome-wide association study of serum lipoprotein (a) in the Jackson Heart Study.J Hum Genet. 2015 Dec;60(12):755-61. doi: 10.1038/jhg.2015.107. Epub 2015 Sep 17. J Hum Genet. 2015. PMID: 26377243 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous